Global Information
회사소개 | 문의 | 비교리스트

세계의 분자진단 시장 : 기술, 용도, 최종 이용 분야별 분석

Global Molecular Diagnostics Market - Technologies, Products, Applications and End-Use Sectors

리서치사 Industry Experts
발행일 2020년 06월 상품 코드 940960
페이지 정보 영문 554 Pages, 381 Charts
가격
US $ 4,860 ₩ 5,446,000 PDF (Single User License)
US $ 7,560 ₩ 8,472,000 PDF (Global Site License)


세계의 분자진단 시장 : 기술, 용도, 최종 이용 분야별 분석 Global Molecular Diagnostics Market - Technologies, Products, Applications and End-Use Sectors
발행일 : 2020년 06월 페이지 정보 : 영문 554 Pages, 381 Charts

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 분자진단 시장은 2019년 108억 5,000만 달러를 기록했습니다. 분자진단 시장은 코로나19의 영향으로 수요 급증이 전망됩니다. 2019-2022년간 14.9%의 연평균 복합 성장률(CAGR)로 성장할 전망이며, 2020년에는 150억 달러 이상에 달할 것으로 예측됩니다.

세계의 분자진단(Molecular Diagnostics) 시장에 대해 조사했으며, 시장 기회 및 동향, 기술·제품 종류·용도·최종 용도·지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 전해드립니다.

목차

Part A : 세계 시장 전망

제1장 서론

제2장 주요 시장 동향

  • 새로운 COVID-19 검사에서 보장된 더 빠른 결과
  • COVID-19 팬데믹에 의한 한국의 검사 키트 수요
  • COVID-19 식별을 위해 개발된 새로운 CRISPR 기반 기술 등

제3장 세계 주요 기업

  • Abbott Diagnostics(미국)
  • Agendia NV(네덜란드)
  • Agilent Technologies, Inc.(미국)
  • Becton, Dickinson and Company(미국)
  • Biom & eacute; rieux SA(프랑스)
  • Bio-Rad Laboratories, Inc.(미국)
  • Danaher Corporation(미국)
  • DNA Diagnostics Center(미국)
  • Elitechgroup(프랑스)
  • Exact Sciences Corporation(미국)
  • F. Hoffmann-La Roche Ag(스위스)
  • Genmark Diagnostics, Inc.(미국)
  • Global Life Sciences Solutions USA LLC(Cytiva)(미국)
  • Grifols International, SA(스페인)
  • Hologic, Inc.(미국)
  • Illumina, Inc.(미국)
  • Kaneka Eurogentec SA(벨기에)
  • Laboratory Corporation of America & reg; Holdings(미국)
  • Luminex Corporation(미국)
  • Merck KGaA(Merck Millipore)(미국)
  • Myriad Genetics, Inc.(미국)
  • Origene Technologies, Inc.(미국)
  • Ortho Clinical Diagnostics(미국)
  • Oxford Gene Technology(영국)
  • Perkinelmer Inc.(미국)
  • Promega Corporation(미국)
  • Qiagen NV(네덜란드)
  • Savyon Diagnostics(이스라엘)
  • Seegene Inc.(한국)
  • Siemens Healthcare GmbH(독일)
  • Sorenson Genomics, LLC(미국)
  • Sysmex Inostics GmbH(독일)
  • Thermo Fisher Scientific Inc.(미국)
  • Transgenomic Inc.(미국)
  • Wuxi Nextcode(중국)

제4장 주요 기업 동향

  • Roche의 Elecsys® Anti-SARS-CoV-2 항체검사가 FDA의 긴급 사용 허가를 취득
  • Grifols에 따르면 SARS-CoV-2 바이러스를 검출하는 분자검사 개발
  • Merck의 Introductory CRISPR-Cas9 기술이 미국 특허 취득
  • mCRPC 및 난소 암 환자에서 Lynparza®의 동반 진단으로 사용하기 위한 Myriad의 BRACAnalysis CDx® 및 myChoice CDx® 테스트에 대한 FDA 승인
  • Siemens Healthineers의 SARS-CoV-2 항체 검사의 세계 출하량
  • Ortho의 두번째 COVID-19 항체 검사에서 CE 마크를 획득
  • TBG Diagnostics의 COVID-19 핵산 항체 신속검사 키트의 CE 마크 승인
  • Open Philanthropy는 COVID-19 진단시약을 개발하기 위해 Sherlock Innovation Lab을 위한 750만 달러의 자금을 지원
  • Bosch와 BioGX가 Vivalytic 플랫폼의 새로운 시험법을 공동 개발/상품화
  • Bioneer의 독자적인 COVID-19에 대한 RT-PCR 분자진단 장비 수주 쇄도
  • Thermo Fisher Scientific이 WuXi Diagnostics, Mayo Clinic과 협력하여 COVID-19 항체 검사를 개발
  • Seegene의 COVID-19 검사 키트 1,000만회 분량을 PAHO/WHO에 수출, 기타

제5장 세계 시장 개요

  • 기술별
    • 지역별
  • 제품 유형별
    • 지역별
  • 용도별
    • 지역별
  • 최종 사용 분야별
    • 지역별

Part B : 지역 시장 전망

지역 시장 시장 개요

제6장 북미

  • 분자진단 시장 개요
  • 기술별
  • 제품 유형별
  • 용도별
  • 최종 이용 분야별
  • 주요 시장 진출기업
  • 국가별 시장 분석

제7장 유럽

제8장 아시아태평양

제9장 기타 지역

Part C : 업계 가이드

  • 1. 북미
  • 2. 유럽
  • 3. 아시아태평양
  • 4. 기타 지역

Part D : 부록

  • 1. 조사 방법
  • 2. 피드백

차트 및 그래프

Part A : 세계 시장 전망

Part B : 지역 시장 전망

지역 시장 개요

북미

미국

캐나다

멕시코

유럽

독일

프랑스

영국

이탈리아

스페인

기타 유럽

아시아태평양

중국

일본

인도

한국

기타 아시아태평양

기타 지역

브라질

아르헨티나

이스라엘

기타 지역

LSH 20.06.29

Report Synopsis

Amid COVID-19 outbreak, the global market for Molecular Diagnostics has created mixed opportunities for manufacturers all over the world. While some of the application segments, such as infectious diseases, is projected to record the highest growth during the pandemic period of 2019-2022, but other applications such as oncology etc. are estimated to face a reduction in demand during the same period.

Global Molecular Diagnostics market has generated a revenue of US$10.85 billion in 2019, and is estimated to be just over US$15 billion in 2020. During 2019 to 2022 period, which is said to be influenced by the Covid-19 pandemic, Infectious Diseases segment is anticipated to gain rapid demand, growing at a robust CAGR of 14.9%. Infectious Diseases segment, in which Covid-19 testing is a part, is estimated to generate an extra revenue of US$3.8 billion globally in 2020 compared to 2019.

Research Findings &Coverage

  • This most comprehensive report on Molecular Diagnostics, analyzes the global market with respect to technologies, product types, applications and end-use sectors
  • Molecular Diagnostics' market size is estimated in this report by product types, technologies, applications and end-use sectors across all major countries
  • Molecular Diagnostics Take the Center Stage in COVID-19 Testing
  • COVID-19 Pandemic Takes Korean Testing Kits Demand to New Heights
  • New CRISPR-Based Technology Developed for COVID-19 Identification
  • Molecular Diagnostics of Infectious Diseases Undergo Dramatic Advancements
  • Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
  • Major companies profiled - 46
  • The industry guide includes the contact details for 169 companies

Product Outline

The report analyzes the market for the following key technologies of Molecular Diagnostics:

  • PCR
  • Sequencing
  • Hybridization
  • Other

The market for key product types of Molecular Diagnostics studied in this report comprise the following:

  • Reagents & Consumables
  • Instruments
  • Software & Services

The market for major applications of Molecular Diagnostics explored in this report comprise the following:

  • Infectious Diseases
  • Oncology
  • Blood Testing
  • Genetic Testing
  • Prenatal Testing
  • Other

The report analyzes the market for the following end-use sectors of Molecular Diagnostics:

  • Hospitals & Diagnostics Labs
  • Research Institutes & Universities
  • Other

Analysis Period, Units and Growth Rates

The report reviews, analyzes and projects the global Molecular Diagnostics market for the period 2017-2026 in terms of market value in US$ and the compound annual growth rates (CAGRs) projected from 2019 through 2026.

Geographic Coverage

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Italy, Spain and Rest of Europe)
  • Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific)
  • Rest of World (Brazil, Argentina, Israel and Other Countries)

Table of Contents

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION

  • 1.1. Product Outline
    • 1.1.1. Significance of Diagnostics
    • 1.1.2. Molecular Diagnostics Defined
      • 1.1.2.1. Molecules Detected Via Molecular Diagnostics
        • 1.1.2.1.1. Chromosome
        • 1.1.2.1.2. DNA
        • 1.1.2.1.3. RNA
        • 1.1.2.1.4. Genes
        • 1.1.2.1.5. Proteins
      • 1.1.2.2. A Historic Review of Molecular Diagnostics
      • 1.1.2.3. Basic Steps Involved in Molecular Diagnostics Assay
      • 1.1.2.4. Sample Collection and Storage
      • 1.1.2.5. Uses of Molecular Diagnostics
      • 1.1.2.6. Technologies of Molecular Diagnostics
        • 1.1.2.6.1. Polymerase Chain Reaction (PCR)
          • 1.1.2.6.1.1. Real Time PCR
          • 1.1.2.6.1.2. Reverse Transcription-PCR
        • 1.1.2.6.2. Sequencing
        • 1.1.2.6.3. Hybridization
          • 1.1.2.6.3.1. Nucleic Acid Hybridization
          • 1.1.2.6.3.2. In situ Hybridization
          • 1.1.2.6.3.3. FISH
        • 1.1.2.6.4. Immunohistochemistry
        • 1.1.2.6.5. NAAT- Nucleic Acid Amplification Technologies
          • 1.1.2.6.5.1. Ligase chain reaction (LCR)
          • 1.1.2.6.5.2. Strand Displacement Amplification (SDA)
          • 1.1.2.6.5.3. Rolling Circle Amplification
          • 1.1.2.6.5.4. Multiplex Ligation-Dependent Probe Amplification (MLPA)
          • 1.1.2.6.5.5. Other
        • 1.1.2.6.6. Microarray
          • 1.1.2.6.6.1. DNA microarrays
          • 1.1.2.6.6.2. Protein or Peptide Chips
        • 1.1.2.6.7. Nanotechnology
          • 1.1.2.6.7.1. Gold Nanoparticles
          • 1.1.2.6.7.2. Quantum Dots
          • 1.1.2.6.7.3. Magnetic Nanoparticles
          • 1.1.2.6.7.4. Nanobiosensors
          • 1.1.2.6.7.5. SEensing of Phage-Treggered Ion Cascade (SEPTIC)
      • 1.1.2.7. Product Types of Molecular Diagnostics
        • 1.1.2.7.1. Reagents and Consumables
          • 1.1.2.7.1.1. Probes
            • 1.1.2.7.1.1.1. DNA probes
            • 1.1.2.7.1.1.2. Genetic probes
            • 1.1.2.7.1.1.3. Molecular Probes
          • 1.1.2.7.1.2. Primers
          • 1.1.2.7.1.3. PCR Reagents
        • 1.1.2.7.2. Instruments
        • 1.1.2.7.3. Software & Services
      • 1.1.2.8. Applications of Molecular Diagnostics
        • 1.1.2.8.1. Infectious Diseases
          • 1.1.2.8.1.1. Hospital Acquired Infections
          • 1.1.2.8.1.2. Blood Infections
          • 1.1.2.8.1.3. Respiratory Tract Infection
          • 1.1.2.8.1.4. Influenza virus Detection
        • 1.1.2.8.2. Oncology
          • 1.1.2.8.2.1. Circulating Tumor Cells or DNA Diagnosis
          • 1.1.2.8.2.2. Risk Assessment
          • 1.1.2.8.2.3. Diagnosis and Differential Diagnosis
          • 1.1.2.8.2.4. Prognosis
          • 1.1.2.8.2.5. Anticipation of Therapeutic Response
          • 1.1.2.8.2.6. Monitorization of Therapeutic Response
          • 1.1.2.8.2.7. Monitoring Recurrence in Asymptomatic Cancer Patients
        • 1.1.2.8.3. Blood Testing
          • 1.1.2.8.3.1. HIV/HCV Testing
        • 1.1.2.8.4. Genetic Testing
        • 1.1.2.8.5. Prenatal Testing
          • 1.1.2.8.5.1. Types of Prenatal Tests
            • 1.1.2.8.5.1.1. Screening Test
            • 1.1.2.8.5.1.2. Diagnostics Test
              • Chorionic villus sampling - (CVS)
              • Aminocentesis
        • 1.1.2.8.6. Agriculture Applications
        • 1.1.2.8.7. Veterinary Application
        • 1.1.2.8.8. Dairy Application
      • 1.1.2.9. End-Use Applications of Molecular Diagnostics
        • 1.1.2.9.1. Hospitals and Diagnostics Labs
        • 1.1.2.9.2. Research Institutes and Universities
        • 1.1.2.9.3. Other
          • 1.1.2.9.3.1. Blood Banks

2. KEY MARKET TRENDS

  • 2.1. Speedier Results Promised by New Test for COVID-19
  • 2.2. COVID-19 Pandemic Takes Korean Testing Kits Demand to New Heights
  • 2.3. New CRISPR-Based Technology Developed for COVID-19 Identification
  • 2.4. Tracing Incidences of Salmonella Food-Poisoning to be Enhanced through New DNA Test
  • 2.5. Molecular Diagnostics of Infectious Diseases Undergo Dramatic Advancements
  • 2.6. Monitoring Treatment of Residual Disease in High-Risk Neuroblastoma Patients Facilitated by Innovative Method
  • 2.7. Time for Diagnosing Sepsis Shortened Significantly Via Novel Next-Generation Sequencing Technique
  • 2.8. Monitoring Antimalarial Drug Resistance Made Easier by Blood Drop Assay
  • 2.9. Silicon Based-Nanostructured Microfluidics - A Novel Molecular Diagnostic Technology for Fetal Aneuploidy
  • 2.10. Creation of Novel and Powerful Adaptive PCR Technique for Rapid Genetic Analysis
  • 2.11. Web Tool Foretells Phenotypes Using little DNA Sample
  • 2.12. Emergence of CRISPR as a Novel Molecular Diagnostic Tool

3. KEY GLOBAL PLAYERS

  • Abbott Diagnostics (United States)
  • Agendia NV (The Netherlands)
  • Agilent Technologies, Inc. (United States)
  • Becton, Dickinson and Company (United States)
  • Biomérieux SA (France)
  • Bio-Rad Laboratories, Inc. (United States)
  • Danaher Corporation (United States)
  • DNA Diagnostics Center (United States)
  • Elitechgroup (France)
  • Exact Sciences Corporation (United States)
  • F. Hoffmann-La Roche Ag (Switzerland)
  • Genmark Diagnostics, Inc. (United States)
  • Global Life Sciences Solutions USA LLC (Cytiva) (United States)
  • Grifols International, S.A. (Spain)
  • Hologic, Inc. (United States)
  • Illumina, Inc. (United States)
  • Kaneka Eurogentec S.A. (Belgium)
  • Laboratory Corporation of America® Holdings (United States)
  • Luminex Corporation (United States)
  • Merck KGaA (Merck Millipore) (United States)
  • Myriad Genetics, Inc. (United States)
  • Origene Technologies, Inc. (United States)
  • Ortho Clinical Diagnostics (United States)
  • Oxford Gene Technology (United Kingdom)
  • Perkinelmer Inc. (United States)
  • Promega Corporation (United States)
  • Qiagen N.V. (The Netherlands)
  • Savyon Diagnostics (Israel)
  • Seegene Inc. (South Korea)
  • Siemens Healthcare GmbH (Germany)
  • Sorenson Genomics, LLC (United States)
  • Sysmex Inostics GmbH (Germany)
  • Thermo Fisher Scientific Inc. (United States)
  • Transgenomic Inc. (United States)
  • Wuxi Nextcode (China)

4. KEY BUSINESS TRENDS

  • Roche's Elecsys® Anti-SARS-CoV-2 Antibody Test Receives FDA Emergency Use Authorization
  • Grifols' Molecular Test to Detect SARS-CoV-2 Virus Developed
  • Merck's Introductory CRISPR-Cas9 Technology Awarded US Patents
  • FDA Approval for Myriad's BRACAnalysis CDx® and myChoice CDx® Tests for Use as a Companion Diagnostic for Lynparza® in Patients with mCRPC and Advanced Ovarian Cancer
  • Global Shipment of Siemens Healthineers SARS-CoV-2 Total Antibody Test
  • CE Mark for Ortho's Second COVID-19 Antibody Test
  • CE Mark Approval for TBG Diagnostics' COVID-19 Nucleic Acid and Antibody Rapid Test Kits
  • Open Philanthropy Funded $7.5 Million to Launch Sherlock Innovation Lab to Develop COVID-19 Diagnostics
  • Bosch and BioGX Joined Forces to Develop and Commercialize New Tests for Vivalytic Platform
  • Bioneer Flooded with Orders for Its Proprietary RT-PCR Molecular Diagnostic Equipment for COVID-19
  • Thermo Fisher Scientific Partners with WuXi Diagnostics and Mayo Clinic to Develop Total Antibodies Test for COVID-19
  • Export of 10 Million Tests of Seegene's COVID-19 Test Kits to PAHO / WHO
  • Danaher's Acquisition of GE's BioPharma Business Results in the Creation of Cytiva
  • Hologic's Second High-Throughput Molecular Assay for COVID-19 to be Unveiled
  • FDA Emergency Use Authorization Granted to Luminex for its ARIES® SARS-CoV-2 Assay
  • MilliporeSigma's New CRISPR technology Given a US Patent
  • Mylab and Syngene Form Covid-19 Test Kits Production Pact
  • Mobidiag Received Emergency Use Authorization in Finland for Its Novodiag® COVID-19 Test
  • Second FDA Emergency Use Authorization, and CE Mark Received by the New BD COVID-19 Test
  • FDA Emergency Use Authorization for Seegene's Allplex™ 2019-nCoV Assay
  • Over 10 million tests of Allplex™ 2019-nCoV Assay Exported to Over 60 Nations Globally
  • Agendia Announces Publication of Study Validating Long Term Analytical Performance Characteristics of 80-Gene BluePrint® Molecular Subtyping Assay
  • InDRE Approves Sale of Co-Diagnostics' Logix Smart™ Coronavirus COVID-19 Test in Mexico
  • Promega GoTaq® Probe 1-Step RT-qPCR System Now in CDC COVID-19 Diagnostic Protocol for Emergency Use
  • Launch of Siemens Healthineers' Molecular FTD SARS-CoV-2 Assay Test Kit
  • Myriad's BRACAnalysis Diagnostic System Now Available to Assess HBOC Risk in Breast and Ovarian Cancer Patients
  • Launch of Qiagen's FDA-Approved therascreen® BRAF V600E RGQ PCR Kit as a Companion Diagnostic to BRAFTOVI®
  • CODX and Promega Collaborate on COVID-19 Test Kits Production
  • ELITechGroup and OSANG Secure FDA Emergency Use Authorization for COVID-19 Test Kits
  • Fosun Receives FDA Emergency Use Authorization COVID-19 RT-PCR Detection Kit
  • FDA Approval for Roche's Cobas® HPV Test for Cervical Cancer
  • Bio-Rad Receives US FDA Approval for ddPCR COVID-19 Assay
  • Cepheid, Inc Receives Emergency Use Authorization (EUA) Policy Approval from U.S. FDA for Xpert® Xpress SARS-CoV-2 Diagnostic Test
  • CODX's JV CoSara India to Manufacture RT-PCR COVID-19 Test Kits
  • CODX's CE-IVD Logix Smart™ COVID-19 Test Kit Demand Surge
  • ELITechGroup Unveils GeneFinderTM COVID-19 Plus RealAmp Kit
  • Roche's Cobas® SARS-CoV-2 Test Receives FDA Emergency Use Authorization
  • CINtec® PLUS Cytology Test from Roche Obtains FDA Approval
  • Roche Deploys 400K Coronavirus Test Kits to the U.S Hospitals and Laboratories
  • Thermo Scientific AcroMetrix COVID-19 RNA Control Now Available for Monitoring and Validating COVID-19 Molecular Diagnostic Tests
  • FDA Emergency Use Authorization and CE Mark for Qiagen's QIAstat-Dx Respiratory SARS-CoV-2 Panel Test
  • Critical Rise in the Global Production Capacity of Qiagen's RNA Extraction Kits to Detect Corona Virus
  • Release of Abbott ID NOW™ COVID-19 Test for Corona Virus Detection in Five Minutes
  • Launch of Abbott RealTime SARS-COV-2 EUA Test for Corona Virus Detection
  • Launch of BioMedomics' New Point-of-Care Serology Test to Detect Exposure to COVID-19
  • NuProbe and Qiagen Join Forces to Develop NGS-Based Cancer Diagnostic Tests for Non-Invasive Liquid Biopsy
  • US FDA Offers Emergency Use Authorization for bioMérieux' BIOFIRE® COVID-19 Test
  • bioMérieux Launched SARS-COV-2 R-GENE® Test
  • Emergency Use Authorization Requests Submitted by BD and BioGX for Use of New COVID-19 Tests in US
  • Qiagen to be Acquired by Thermo Fisher Scientific
  • CE Mark for VIASURE SARS-COV-2 RT-PCR Detection Kit Adapted for BD MAX™ System
  • GE's Divestment of BioPharma Business to Danaher Completed
  • COVID-19 Diagnostic Testing Kit from Cytiva Launched
  • GenMark's ePlex® SARS-CoV-2 Test Granted Emergency Use Authorization by the US FDA
  • GenMark Diagnostics' ePlex® RUO Test Kits Commence Shipments Globally
  • FDA Emergency Use Authorization Given to Hologic's Molecular Test for SARS-CoV-2
  • Hologic and LabCorp Granted US FDA's COVID-19 Diagnostic Emergency Use Authorization
  • NxTAG® CoV Extended Panel from Luminex Granted FDA EUA
  • Hologic's Scalable Versions of Panther System Introduced
  • Luminex's VERIGENE® II Respiratory Flex Assay Submitted for FDA Clearance
  • Elypta's Liquid Biopsy Kits to be Made by MilliporeSigma
  • Launch of Seegene's Allplex™ 2019-nCoV Assay in Korea
  • Bio-Rad Unveils EDX Respiratory Panel (RP) Positive Run Control for Molecular Assay Use
  • Bio-Rad Acquires Exact Diagnostics LLC
  • Cepheid and Sherlock Biosciences Collaborate on Developing Molecular Diagnostic Tests
  • FDA Approval for Cepheid's Xpert® BCR-ABL Ultra Test
  • Roche to Expand its Diagnostics Business in South Africa
  • GE Healthcare's Sera-Xtracta Isolation Kits for Cell-Free and Genomic DNA Introduced
  • Illumina and Roche Collaborate for Providing Greater Genomic Testing Access to Patients
  • Joint Development of Molecular Diagnostic Tests by SpeeDx and LabCorp
  • Launch of Qiagen Clinical Insights Precision Insights in Europe
  • ArcherDX to Co-Develop In-Vitro Diagnostic Tests with Illumina
  • FDA Approval for Myriad's BRACAnalysis CDx® Test for Use as a Companion Diagnostic for Lynparza® in Metastatic Pancreatic Cancer Patients having Germline BRCA Mutation
  • License Deal Signed by Promega to Access MilliporeSigma's Foundational CRISPR Genome-Editing Technology
  • Thermo Fisher Scientific to Launch Ion Torrent Oncomine Myeloid Research Assay to Simplify and Accelerate the Genomic Profiling Process
  • Codexis Agree to Provide Roche with High-Performance Molecular Diagnostic Enzyme
  • Roche Develops Cobas® Zika Blood Screening Test Kit
  • ELITechGroup, Inc Extends its Direct Sales and Customer Support Services in Canada
  • Exact Sciences and Genomic Health Merge
  • Japanese Regulatory Approval for Myriad's BRACAnalysis® Diagnostic System
  • Launch of Thermo Fisher Scientific's Ion Torrent Genexus System
  • Illumina and QIAGEN in a Partnership
  • Luminex's ARIES® MRSA Assay Granted FDA 510(k) Clearance
  • FDA Approval for Myriad's myChoice® CDx Test for Use as a Companion Diagnostic for Zejula® in Late-line Ovarian Cancer Patients
  • Launch of Thermo Scientific Acrometrix BCR-ABL Panel
  • Roche Introduces Cobas® EBV and BKV Tests on the Cobas 6800/8800 Systems for Transplant Patients
  • Roche Receives U.S FDA Approval for Cobas® Babesia Test
  • US FDA Approved Thermo Fisher Scientific's ImmunoCAP Allergen Components test for Furry Animal for In Vitro Diagnostic Use
  • MilliporeSigma in an Agreement with Broad Institute
  • Exact Sciences' New Laboratory Opens
  • Roche Molecular Shut Down its Production Site in California
  • Invisible Sentinel Acquired by bioMérieux
  • BD COR™ System Receives CE-IVDD Certification in Europe
  • Seegene to Broaden its Market Presence in Latin American IVD Market
  • Validation Studies of Agendia's MammaPrint® and BluePrint® Using RNA Next-Generation Sequencing Technology Published in the Journal of Molecular Diagnostics
  • Hologic's Aptima® BV and Aptima® CV/TV Molecular Assays Cleared by US FDA
  • Agendia Joined Forces with Imegen for Exclusive Distribution of Breast Cancer Genomic Tests in Spain and Portugal
  • FDA Approval Qiagen's therascreen® PIK3CA RGQ PCR Kit as a Companion Diagnostic for Novartis' Piqray in Breast Cancer Patients
  • Cepheid Receives FDA Approval for Xpert® CT/NG Test
  • Roche Develops VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody
  • Roche Introduces Cobas® MTB-RIF/INH Test Used in Tuberculosis DNA Analysis
  • GenMark Diagnostics' ePlex Blood Culture Identification Gram-Negative Panel Given FDA 510(k) Market Clearance
  • HTG Molecular and Illumina Expand Association
  • QIAGEN and LabCorp in a Partnership for the Former's "Day-One" Program
  • Launch of Qiagen's Latest therascreen FGFR RGQ RT-PCR Kit in US
  • Thermo Fisher Scientific Releases First-of-its-kind Commercial MicroED Solution
  • Thermo Fisher Scientific Join Forces with NX Prenatal to Develop Clinical Mass Spectrometry-Based Proteomics Assays
  • Opening of Wuxi NextCODE's New Genetic Analysis Laboratory in United States
  • CE Mark for Abbott's Alinity™ m Diagnostics System and Assays
  • Two CE Marks for Aptima HIV-1 Quant Dx Assay from Hologic
  • Cytiva's SeraSil-Mag Silica Particles Launched
  • Savyon Introduces Savvygen STI RT-PCR Assays for STI
  • USDA Grants a Contract to Bio-Rad In View of Pathogen Detection
  • Supply Contract Made by OncoDNA in Romania and Turkey
  • Release of Novel Molecular Diagnostics Test for TB by BD
  • Introduction of TruSightTM Oncology 500 by Illumina
  • Adoption of EdgeSeq Technology of HTG in IOR's Genomics Hub
  • Major Stakes of Hain Lifescience Taken Over by Bruker
  • QIAGEN Join Forces with NeuMoDx to Provide NGS for Completely Incorporated MDx
  • Chinese Launch of MammaPrint and BluePrint of Agendia In Association with Genecast
  • Introduction of a Novel Real Time PCR Analysis Technology by Seegene
  • Commercial Release of OncoBEAM™ EGFR Kit v2 (RUO) in Europe and Asia by Sysmex
  • QIAGEN Extends Its Footprints In Africa By Collaborating With The Scientific Group
  • Admera Signs a Partnership Deal with Quadrant
  • Savyon is ready to Release Savvygen Lyophilized RT-PCR Assays for Stomach Flu
  • Rapid DNA Analyis Technology Offered by Thermo Fisher for Reassembling
  • Release of Ion AmpliSeq HD Technology by Thermo Fisher
  • Introduction of QIAseq 16S Panels and UCP Multiplex PCR kit by QIAGEN for Microbiome Profiling
  • Release of Novel Probes for In Situ Hybridization Protocols
  • Initiation of Clinical Studies of VERIGENE® II Gastrointestinal Assay by Luminex
  • MammaPrint and BluePrint of Agendia are Now Accessible in SouthEast Asia Via Angsana
  • Unicancer Adopts MammaPrint and BluePrint of Agendia in France
  • Expansion of Real-Time PCR assay Collection by R-Biopharm and ELITechGroup
  • Roche, DIAN and Foundation Medicine Join Forces to Enhance Chinese Tailored Cancer care
  • Expansion of In Situ Hybridization Probes Panel for Clinical Access by Agilent
  • Natera Join Forces with QIAGEN to Design Advanced Genetic Testing Assays
  • Introduction of Novel CE marked Assay by QIAGEN to Detect Trichomonas
  • Introduction of ccfDNA Blood Collection Tube by BD
  • Commercial Release of Oncotype DX® AR-V7 Nucleus Detect™ Test by Genomic Health
  • QIAGEN to Take Over STAT-Dx
  • Illumina Join Forces with KingMed to Design NGS Technology for CFDA Clearance
  • World's Foremost Multiplex MDx Assay Designed by Seegene
  • Launch of Novel Salmonella Multiplex PCR Solution by Thermo Fisher
  • Agendia Alliance with Bluebee for Commercial Release of NGS-Based MammaPrint BluePrint
  • Co validation of MammaPrint BluePrint By Agendia and UZ Leuven Before EU Release
  • Agendia Alliances with Institut Curie to Co Validate MammaPrint BluePrint Breast Cancer kit
  • Release of NetSeqTM 550Dx System by Illumina
  • Extension of Respiratory Disease Panel by Cepheid
  • Launch of Custom Solutions Business by QIAGEN to Assist MDx and Life Science Firms
  • AutoGenomics Partners With LCM for Precision Medicine
  • Admera Extends its Existence in Asia through 3 Alliances
  • Release of riskScoreTM by Myriad to Detect Hereditary Cancer
  • Luminex and Sutter Join Forces To Offer Multiple Luminex Diagnostic Systems
  • Savyon Launches Multiplex Lyophilized RT-PCR Assays for Respiratory illness
  • HomeDNATM Now Accessible Throughout the Nation
  • Helix Collaborates With Admera to Offer Genetic Tests For Cardiology Related Ailments
  • European Launch of Real-Time PCR System for Clinical Diagnostics by Agilent
  • Agendia Collaborates With Agilent for Molecular Cancer Diagnostics
  • European Release of cobas® MRSA/SA test By Roche
  • Release of HTG EdgeSeq PATH Assay By HTG
  • Admera Alliances with University of Rochester to Evaluate Pharmacogenomics
  • Thermo Fisher and Seegene Partners to File for U.S FDA Clearance
  • Launch of Second Generation Real Time PCR Technology by Seegene
  • Instituto Valenciano de Oncología and HTG Partner to Assess Breast Cancer reappearance Risk
  • Launch of GenetiSure Dx Postnatal Assay By Agilent To Detect Genetic Anomalies
  • Multiplicom Completely Taken Over by Agilent
  • Seegene Unveils a Novel Normalization Software Technology for MDx
  • Adoption of ICE COLD-PCR of Transgenomic by LifeLabs
  • NAT Donor Screening Unit of Hologic Taken Over by Grifols

5. GLOBAL MARKET OVERVIEW

  • 5.1. Global Molecular Diagnostics Market Overview by Technology
    • 5.1.1. Molecular Diagnostics Technologies Market Overview by Global Region
      • 5.1.1.1. PCR
      • 5.1.1.2. Sequencing
      • 5.1.1.3. Hybridization
      • 5.1.1.4. Other Technologies
  • 5.2. Global Molecular Diagnostics Market Overview by Product Type
    • 5.2.1. Molecular Diagnostics Products Market Overview by Global Region
      • 5.2.1.1. Reagents & Consumables
      • 5.2.1.2. Instruments
      • 5.2.1.3. Software & Services
  • 5.3. Global Molecular Diagnostics Market Overview by Application
    • 5.3.1. Molecular Diagnostics Applications Market Overview by Global Region
      • 5.3.1.1. Infectious Diseases
      • 5.3.1.2. Oncology
      • 5.3.1.3. Blood Testing
      • 5.3.1.4. Genetic Testing
      • 5.3.1.5. Prenatal Testing
      • 5.3.1.6. Other Applications
  • 5.4. Global Molecular Diagnostics Market Overview by End-Use Sector
    • 5.4.1. Molecular Diagnostics End User Market Overview by Global Region
      • 5.4.1.1. Hospitals & Diagnostics Labs
      • 5.4.1.2. Research Institutes & Universities
      • 5.4.1.3. Other End-Use Sectors

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

6. NORTH AMERICA

  • 6.1. North American Molecular Diagnostics Market Overview by Geographic Region
  • 6.2. North American Molecular Diagnostics Market Overview by Technology
    • 6.2.1. Molecular Diagnostics Technologies Market Overview by NA Region
      • 6.2.1.1. PCR
      • 6.2.1.2. Sequencing
      • 6.2.1.3. Hybridization
      • 6.2.1.4. Other Technologies
  • 6.3. North American Molecular Diagnostics Market Overview by Product Type
    • 6.3.1. Molecular Diagnostics Products Market Overview by NA Region
      • 6.3.1.1. Reagents & Consumables
      • 6.3.1.2. Instruments
      • 6.3.1.3. Software & Services
  • 6.4. North American Molecular Diagnostics Market Overview by Applications
    • 6.4.1. Molecular Diagnostics Applications Market Overview by NA Region
      • 6.4.1.1. Infectious Diseases
      • 6.4.1.2. Oncology
      • 6.4.1.3. Blood Testing
      • 6.4.1.4. Genetic Testing
      • 6.4.1.5. Prenatal Testing
      • 6.4.1.6. Other Applications
  • 6.5. North American Molecular Diagnostics Market Overview by End-Use Sector
    • 6.5.1. Molecular Diagnostics End-Use Sector Market Overview by NA Region
      • 6.5.1.1. Hospitals & Diagnostics Labs
      • 6.5.1.2. Research Institutes & Universities
      • 6.5.1.3. Other End-User Sectors
  • 6.6. Major Market Players
    • Abbott Diagnostics (United States)
    • Admera Health (United States)
    • Agilent Technologies, Inc. (United States)
    • Autogenomics, Inc. (United States)
    • Becton, Dickinson and Company (United States)
    • Bio-Rad Laboratories, Inc. (United States)
    • Danaher Corporation (United States)
    • Beckman coulter, Inc. (United States)
    • Cepheid (United States)
    • DNA diagnostics center (United States)
    • Exact Sciences Corporation (United States)
    • Foundation medicine (United States)
    • GenMark Diagnostics, Inc. (United States)
    • Global Life Sciences Solutions USA LLC (Cytiva) (United States)
    • Hologic, Inc. (United States)
    • HTG Molecular Diagnostics, Inc. (United States)
    • Illumina, Inc. (United States)
    • Laboratory Corporation of America ® Holdings (United States)
    • Luminex Corporation (United States)
    • Merck KGaA (Merck Millipore) (United States)
    • Myriad Genetics, Inc. (United States)
    • OriGene Technologies (United States)
    • Ortho Clinical Diagnostics (United States)
    • Pathogenetix, Inc. (United States)
    • PerkinElmer, Inc. (United States)
    • Promega Corporation (United States)
    • Sorenson Genomics, Inc. (United States)
    • Thermo Fisher Scientific, Inc. (United States)
    • Transgenomic, Inc. (United States)
  • 6.7. Country-wise Analysis of North American Molecular Diagnostics Market
    • 6.7.1. The United States
      • 6.7.1.1. United States Molecular Diagnostics Market Overview by Technology
      • 6.7.1.2. United States Molecular Diagnostics Market Overview by Product Type
      • 6.7.1.3. United States Molecular Diagnostics Market Overview by Application
      • 6.7.1.4. United States Molecular Diagnostics Market Overview by End-Use Sector
    • 6.7.2. Canada
      • 6.7.2.1. Canadian Molecular Diagnostics Market Overview by Technology
      • 6.7.2.2. Canadian Molecular Diagnostics Market Overview by Product Type
      • 6.7.2.3. Canadian Molecular Diagnostics Market Overview by Applications
      • 6.7.2.4. Canadian Molecular Diagnostics Market Overview by End-Use Sector
    • 6.7.3. Mexico
      • 6.7.3.1. Mexican Molecular Diagnostics Market Overview by Technology
      • 6.7.3.2. Mexican Molecular Diagnostics Market Overview by Product Type
      • 6.7.3.3. Mexican Molecular Diagnostics Market Overview by Applications
      • 6.7.3.4. Mexican Molecular Diagnostics Market Overview by End-Use Sector

7. EUROPE

  • 7.1. European Molecular Diagnostics Market Overview by Geographic Region
  • 7.2. European Molecular Diagnostics Market Overview by Technology
    • 7.2.1. Molecular Diagnostics Technologies Market Overview by European Region
      • 7.2.1.1. PCR
      • 7.2.1.2. Sequencing
      • 7.2.1.3. Hybridization
      • 7.2.1.4. Other Technologies
  • 7.3. European Molecular Diagnostics Market Overview by Product Type
    • 7.3.1. Molecular Diagnostics Product Type Market Overview by European Region
      • 7.3.1.1. Reagents & Consumables
      • 7.3.1.2. Instruments
      • 7.3.1.3. Software & Services
  • 7.4. European Molecular Diagnostics Market Overview by Applications
    • 7.4.1. Molecular Diagnostics Applications Market Overview by European Region
      • 7.4.1.1. Infectious Diseases
      • 7.4.1.2. Oncology
      • 7.4.1.3. Blood Testing
      • 7.4.1.4. Genetic Testing
      • 7.4.1.5. Prenatal Testing
      • 7.4.1.6. Other Applications
  • 7.5. European Molecular Diagnostics Market Overview by End-Use Sector
    • 7.5.1. Molecular Diagnostics End-Use Sector Market Overview by European Region
      • 7.5.1.1. Hospitals & Diagnostics Labs
      • 7.5.1.2. Research Institutes & Universities
      • 7.5.1.3. Other End-Use Sectors
  • 7.6. Major Market Players
    • Agendia NV (The Netherlands)
    • Analytik Jena (Germany)
    • BioMerieux SA (France)
    • ELITechGroup (France)
    • F. Hoffmann-La Roche AG (Switzerland)
    • Grifols International S.A (Spain)
    • Kaneka Eurogentec S.A (Belgium)
    • Oxford Gene Technology (The United Kingdom)
    • QIAGEN N.V. (The Netherlands)
    • Siemens Healthcare GmbH (Germany)
    • Sysmex Inostics GmbH (Germany)
  • 7.7. Country-wise Analysis of European Molecular Diagnostics Market
    • 7.7.1. Germany
      • 7.7.1.1. German Molecular Diagnostics Market Overview by Technology
      • 7.7.1.2. German Molecular Diagnostics Market Overview by Product Type
      • 7.7.1.3. German Molecular Diagnostics Market Overview by Application
      • 7.7.1.4. German Molecular Diagnostics Market Overview by End-Use Sector
    • 7.7.2. France
      • 7.7.2.1. French Molecular Diagnostics Market Overview by Technology
      • 7.7.2.2. French Molecular Diagnostics Market Overview by Product Type
      • 7.7.2.3. French Molecular Diagnostics Market Overview by Application
      • 7.7.2.4. French Molecular Diagnostics Market Overview by End-Use Sector
    • 7.7.3. The United Kingdom
      • 7.7.3.1. United Kingdom Molecular Diagnostics Market Overview by Technology
      • 7.7.3.2. United Kingdom Molecular Diagnostics Market Overview by Product Type
      • 7.7.3.3. United Kingdom Molecular Diagnostics Market Overview by Application
      • 7.7.3.4. United Kingdom Molecular Diagnostics Market Overview by End-Use Sector
    • 7.7.4. Italy
      • 7.7.4.1. Italian Molecular Diagnostics Market Overview by Technology
      • 7.7.4.2. Italian Molecular Diagnostics Market Overview by Product Type
      • 7.7.4.3. Italian Molecular Diagnostics Market Overview by Application
      • 7.7.4.4. Italian Molecular Diagnostics Market Overview by End-Use Sector
    • 7.7.5. Spain
      • 7.7.5.1. Spanish Molecular Diagnostics Market Overview by Technology
      • 7.7.5.2. Spanish Molecular Diagnostics Market Overview by Product Type
      • 7.7.5.3. Spanish Molecular Diagnostics Market Overview by Application
      • 7.7.5.4. Spanish Molecular Diagnostics Market Overview by End-Use Sector
    • 7.7.6. Rest of Europe
      • 7.7.6.1. Rest of Europe Molecular Diagnostics Market Overview by Technology
      • 7.7.6.2. Rest of Europe Molecular Diagnostics Market Overview by Product Type
      • 7.7.6.3. Rest of Europe Molecular Diagnostics Market Overview by Application
      • 7.7.6.4. Rest of Europe Molecular Diagnostics Market Overview by End-Use Sector

8. ASIA-PACIFIC

  • 8.1. Asia-Pacific Molecular Diagnostics Market Overview by Geographic Region
  • 8.2. Asia-Pacific Molecular Diagnostics Market Overview by Technology
    • 8.2.1. Molecular Diagnostics Technologies Market Overview by Asia-Pacific Region
      • 8.2.1.1. PCR
      • 8.2.1.2. Sequencing
      • 8.2.1.3. Hybridization
      • 8.2.1.4. Other Technologies
  • 8.3. Asia-Pacific Molecular Diagnostics Market Overview by Product Type
    • 8.3.1. Molecular Diagnostics Product Type Market Overview by Asia-Pacific Region
      • 8.3.1.1. Reagents & Consumables
      • 8.3.1.2. Instruments
      • 8.3.1.3. Software & Services
  • 8.4. Asia-Pacific Molecular Diagnostics Market Overview by Applications
    • 8.4.1. Molecular Diagnostics Applications Market Overview by Asia-Pacific Region
      • 8.4.1.1. Infectious Diseases
      • 8.4.1.2. Oncology
      • 8.4.1.3. Blood Testing
      • 8.4.1.4. Genetic Testing
      • 8.4.1.5. Prenatal Testing
      • 8.4.1.6. Other Applications
  • 8.5. Asia-Pacific Molecular Diagnostics Market Overview by End-Use Sector
    • 8.5.1. Molecular Diagnostics End-Use Sector Market Overview by Asia-Pacific Region
      • 8.5.1.1. Hospitals & Diagnostics Labs
      • 8.5.1.2. Research Institutes & Universities
      • 8.5.1.3. Other End-Use Sectors
  • 8.6. Major Market Players
    • BGI-Shenzhen (China)
    • Dian Diagnostics Group Co., Ltd. (China)
    • Seegene, Inc. (South Korea)
    • Shanghai Runda Medical Technology Co., Ltd. (China)
    • WuXi NextCODE (China)
  • 8.7. Country-wise Analysis of Asia-Pacific Molecular Diagnostics Market
    • 8.7.1. China
      • 8.7.1.1. Chinese Molecular Diagnostics Market Overview by Technology
      • 8.7.1.2. Chinese Molecular Diagnostics Market Overview by Product Type
      • 8.7.1.3. Chinese Molecular Diagnostics Market Overview by Application
      • 8.7.1.4. Chinese Molecular Diagnostics Market Overview by End-Use Sector
    • 8.7.2. Japan
      • 8.7.2.1. Japanese Molecular Diagnostics Market Overview by Technology
      • 8.7.2.2. Japanese Molecular Diagnostics Market Overview by Product Type
      • 8.7.2.3. Japanese Molecular Diagnostics Market Overview by Application
      • 8.7.2.4. Japanese Molecular Diagnostics Market Overview by End-Use Sector
    • 8.7.3. India
      • 8.7.3.1. Indian Molecular Diagnostics Market Overview by Technology
      • 8.7.3.2. Indian Molecular Diagnostics Market Overview by Product Type
      • 8.7.3.3. Indian Molecular Diagnostics Market Overview by Application
      • 8.7.3.4. Indian Molecular Diagnostics Market Overview by End-Use Sector
    • 8.7.4. South Korea
      • 8.7.4.1. South Korean Molecular Diagnostics Market Overview by Technology
      • 8.7.4.2. South Korean Molecular Diagnostics Market Overview by Product Type
      • 8.7.4.3. South Korean Molecular Diagnostics Market Overview by Application
      • 8.7.4.4. South Korean Molecular Diagnostics Market Overview by End-Use Sector
    • 8.7.5. Rest of Asia-Pacific
      • 8.7.5.1. Rest of Asia-Pacific Molecular Diagnostics Market Overview by Technology
      • 8.7.5.2. Rest of Asia-Pacific Molecular Diagnostics Market Overview by Product Type
      • 8.7.5.3. Rest of Asia-Pacific Molecular Diagnostics Market Overview by Application
      • 8.7.5.4. Rest of Asia-Pacific Molecular Diagnostics Market Overview by End-Use Sector

9. REST OF WORLD

  • 9.1. Rest of World Molecular Diagnostics Market Overview by Geographic Region
  • 9.2. Rest of World Molecular Diagnostics Market Overview by Technology
    • 9.2.1. Molecular Diagnostics Technologies Market Overview by RoW Region
      • 9.2.1.1. PCR
      • 9.2.1.2. Sequencing
      • 9.2.1.3. Hybridization
      • 9.2.1.4. Other Technologies
  • 9.3. Rest of World Molecular Diagnostics Market Overview by Product Type
    • 9.3.1. Molecular Diagnostics Product Type Market Overview by ROW Region
      • 9.3.1.1. Reagents & Consumables
      • 9.3.1.2. Instruments
      • 9.3.1.3. Software & Services
  • 9.4. Rest of World Molecular Diagnostics Market Overview by Applications
    • 9.4.1. Molecular Diagnostics Applications Market Overview by ROW Region
      • 9.4.1.1. Infectious Diseases
      • 9.4.1.2. Oncology
      • 9.4.1.3. Blood Testing
      • 9.4.1.4. Genetic Testing
      • 9.4.1.5. Prenatal Testing
      • 9.4.1.6. Other Applications
  • 9.5. Rest of World Molecular Diagnostics Market Overview by End-Use Sector
    • 9.5.1. Molecular Diagnostics End-Use Sector Market Overview by ROW Region
      • 9.5.1.1. Hospitals & Diagnostics Labs
      • 9.5.1.2. Research Institutes & Universities
      • 9.5.1.3. Other End-Use Sectors
  • 9.6. Savyon Diagnostics (Israel) - A Major Market Player
  • 9.7. Country-wise Analysis of Rest of World Molecular Diagnostics Market
    • 9.7.1. Brazil
      • 9.7.1.1. Brazilian Molecular Diagnostics Market Overview by Technology
      • 9.7.1.2. Brazilian Molecular Diagnostics Market Overview by Product Type
      • 9.7.1.3. Brazilian Molecular Diagnostics Market Overview by Application
      • 9.7.1.4. Brazilian Molecular Diagnostics Market Overview by End-Use Sector
    • 9.7.2. Argentina
      • 9.7.2.1. Argentinean Molecular Diagnostics Market Overview by Technology
      • 9.7.2.2. Argentinean Molecular Diagnostics Market Overview by Product Type
      • 9.7.2.3. Argentinean Molecular Diagnostics Market Overview by Application
      • 9.7.2.4. Argentinean Molecular Diagnostics Market Overview by End-Use Sector
    • 9.7.3. Israel
      • 9.7.3.1. Israeli Molecular Diagnostics Market Overview by Technology
      • 9.7.3.2. Israeli Molecular Diagnostics Market Overview by Product Type
      • 9.7.3.3. Israeli Molecular Diagnostics Market Overview by Application
      • 9.7.3.4. Israeli Molecular Diagnostics Market Overview by End-Use Sector
    • 9.7.4. Other ROW Countries
      • 9.7.4.1. Other ROW Countries Molecular Diagnostics Market Overview by Technology
      • 9.7.4.2. Other ROW Countries Molecular Diagnostics Market Overview by Product Type
      • 9.7.4.3. Other ROW Countries Molecular Diagnostics Market Overview by Application
      • 9.7.4.4. Other ROW Countries Molecular Diagnostics Market Overview by End-Use Sector

PART C: GUIDE TO THE INDUSTRY

  • 1. NORTH AMERICA
  • 2. EUROPE
  • 3. ASIA-PACIFIC
  • 4. REST OF WORLD

PART D: ANNEXURE

  • 1. RESEARCH METHODOLOGY
  • 2. FEEDBACK

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVE

  • Chart 1: Global Molecular Diagnostics Market (2019, 2022 & 2026) by Application
  • Chart 2: Global Molecular Diagnostics Market (2019, 2022 & 2026) by Technology
  • Chart 3: Global Molecular Diagnostics Market (2019, 2022 & 2026) by End-Use Sector
  • Chart 4: Global Molecular Diagnostics Market (2019, 2022 & 2026) by Product Type
  • Chart 5: Global Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 6: Global Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 7: Glance at 2017, 2019 and 2026 Global Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 8: Global Market Analysis (2017-2026) for PCR in Molecular Diagnostics by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 9: Glance at 2017, 2019 and 2026 Global Market Share (%) for PCR in Molecular Diagnostics by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 10: Global Market Analysis (2017-2026) for Sequencing in Molecular Diagnostics by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 11: Glance at 2017, 2019 and 2026 Global Market Share (%) for Sequencing in Molecular Diagnostics by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 12: Global Market Analysis (2017-2026) for Hybridization in Molecular Diagnostics by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 13: Glance at 2017, 2019 and 2026 Global Market Share (%) for Hybridization in Molecular Diagnostics by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 14: Global Market Analysis (2017-2026) for Other Technologies in Molecular Diagnostics by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 15: Glance at 2017, 2019 and 2026 Global Market Share (%) for Other Technologies in Molecular Diagnostics by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 16: Global Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 17: Glance at 2017, 2019 and 2026 Global Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 18: Global Molecular Diagnostics Reagents & Consumables Market Analysis (2017-2026) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 19: Glance at 2017, 2019 and 2026 Global Molecular Diagnostics Reagents & Consumables Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 20: Global Molecular Diagnostics Instruments Market Analysis (2017-2026) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 21: Glance at 2017, 2019 and 2026 Global Molecular Diagnostics Instruments Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 22: Global Molecular Diagnostics Software & Services Market Analysis (2017-2026) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 23: Glance at 2017, 2019 and 2026 Global Molecular Diagnostics Software & Services Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 24: Global Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 25: Glance at 2017, 2019 and 2026 Global Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 26: Global Market Analysis (2017-2026) for Molecular Diagnostics in Infectious Diseases by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 27: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Infectious Diseases by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 28: Global Market Analysis (2017-2026) for Molecular Diagnostics in Oncology by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 29: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Oncology by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 30: Global Market Analysis (2017-2026) for Molecular Diagnostics in Blood Testing by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 31: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Blood Testing by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 32: Global Market Analysis (2017-2026) for Molecular Diagnostics in Genetic Testing by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 33: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Genetic Testing by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 34: Global Market Analysis (2017-2026) for Molecular Diagnostics in Prenatal Testing by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 35: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Prenatal Testing by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 36: Global Market Analysis (2017-2026) for Molecular Diagnostics in Other Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 37: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Other Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 38: Global Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 39: Glance at 2017, 2019 and 2026 Global Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other
  • Chart 40: Global Market Analysis (2017-2026) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 41: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 42: Global Market Analysis (2017-2026) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 43: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 44: Global Market Analysis (2017-2026) for Molecular Diagnostics in Other End-Use Sectors by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 45: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Other End Users by Geographic Region - North America, Europe, Asia-Pacific and Rest of World

PART B: REGIONAL MARKET PERSPECTIVE

  • Chart 46: Global Molecular Diagnostics Market Analysis (2017-2026) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 47: Glance at 2017, 2019 and 2026 Global Molecular Diagnostics Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World

REGIONAL MARKET OVERVIEW

NORTH AMERICA

  • Chart 48: North American Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 49: North American Molecular Diagnostics Market Analysis (2017-2026) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 50: Glance at 2017, 2019 and 2026 North American Molecular Diagnostics Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 51: North American Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 52: Glance at 2017, 2019 and 2026 North American Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 53: North American Market Analysis (2017-2026) for PCR in Molecular Diagnostics by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 54: Glance at 2017, 2019 and 2026 North American Market Share (%) for PCR in Molecular Diagnostics by Geographic Region - United States, Canada and Mexico
  • Chart 55: North American Market Analysis (2017-2026) for Sequencing in Molecular Diagnostics by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 56: Glance at 2017, 2019 and 2026 North American Market Share (%) for Sequencing in Molecular Diagnostics by Geographic Region - United States, Canada and Mexico
  • Chart 57: North American Market Analysis (2017-2026) for Hybridization in Molecular Diagnostics by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 58: Glance at 2017, 2019 and 2026 North American Market Share (%) for Hybridization in Molecular Diagnostics by Geographic Region - United States, Canada and Mexico
  • Chart 59: North American Market Analysis (2017-2026) for Other Technologies in Molecular Diagnostics by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 60: Glance at 2017, 2019 and 2026 North American Market Share (%) for Other Technologies in Molecular Diagnostics by Geographic Region - United States, Canada and Mexico
  • Chart 61: North American Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 62: Glance at 2017, 2019 and 2026 North American Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 63: North American Molecular Diagnostics Reagents & Consumables Market Analysis (2017-2026) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 64: Glance at 2017, 2019 and 2026 North American Molecular Diagnostics Reagents & Consumables Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 65: North American Molecular Diagnostics Instruments Market Analysis (2017-2026) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 66: Glance at 2017, 2019 and 2026 North American Molecular Diagnostics Instruments Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 67: North American Molecular Diagnostics Software & Services Market Analysis (2017-2026) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 68: Glance at 2017, 2019 and 2026 North American Molecular Diagnostics Software & Services Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 69: North American Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 70: Glance at 2017, 2019 and 2026 North American Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 71: North American Market Analysis (2017-2026) for Molecular Diagnostics in Infectious Diseases by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 72: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Infectious Diseases by Geographic Region - United States, Canada and Mexico
  • Chart 73: North American Market Analysis (2017-2026) for Molecular Diagnostics in Oncology by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 74: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Oncology by Geographic Region - United States, Canada and Mexico
  • Chart 75: North American Market Analysis (2017-2026) for Molecular Diagnostics in Blood Testing by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 76: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Blood Testing by Geographic Region - United States, Canada and Mexico
  • Chart 77: North American Market Analysis (2017-2026) for Molecular Diagnostics in Genetic Testing by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 78: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Genetic Testing by Geographic Region - United States, Canada and Mexico
  • Chart 79: North American Market Analysis (2017-2026) for Molecular Diagnostics in Prenatal Testing by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 80: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Prenatal Testing by Geographic Region - United States, Canada and Mexico
  • Chart 81: North American Market Analysis (2017-2026) for Molecular Diagnostics in Other Applications by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 82: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Other Applications by Geographic Region - United States, Canada and Mexico
  • Chart 83: North American Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 84: Glance at 2017, 2019 and 2026 North American Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other
  • Chart 85: North American Market Analysis (2017-2026) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 86: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - United States, Canada and Mexico
  • Chart 87: North American Market Analysis (2017-2026) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 88: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - United States, Canada and Mexico
  • Chart 89: North American Market Analysis (2017-2026) for Molecular Diagnostics in Other End-Use Sectors by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 90: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Other End-User Sectors by Geographic Region - United States, Canada and Mexico

The United States

  • Chart 91: United States Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 92: United States Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 93: Glance at 2017, 2019 and 2026 United States Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 94: United States Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 95: Glance at 2017, 2019 and 2026 United States Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 96: United States Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 97: Glance at 2017, 2019 and 2026 United States Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 98: United States Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 99: Glance at 2017, 2019 and 2026 United States Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Canada

  • Chart 100: Canadian Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 101: Canadian Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 102: Glance at 2017, 2019 and 2026 Canadian Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 103: Canadian Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 104: Glance at 2017, 2019 and 2026 Canadian Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 105: Canadian Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 106: Glance at 2017, 2019 and 2026 Canadian Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 107: Canadian Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 108: Glance at 2017, 2019 and 2026 Canadian Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Mexico

  • Chart 109: Mexican Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 110: Mexican Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 111: Glance at 2017, 2019 and 2026 Mexican Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 112: Mexican Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 113: Glance at 2017, 2019 and 2026 Mexican Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 114: Mexican Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 115: Glance at 2017, 2019 and 2026 Mexican Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 116: Mexican Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 117: Glance at 2017, 2019 and 2026 Mexican Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

EUROPE

  • Chart 118: European Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 119: European Molecular Diagnostics Market Analysis (2017-2026) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 120: Glance at 2017, 2019 and 2026 European Molecular Diagnostics Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 121: European Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 122: Glance at 2017, 2019 and 2026 European Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 123: European Market Analysis (2017-2026) for PCR in Molecular Diagnostics by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 124: Glance at 2017, 2019 and 2026 European Market Share (%) for PCR in Molecular Diagnostics by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 125: European Market Analysis (2017-2026) for Sequencing in Molecular Diagnostics by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 126: Glance at 2017, 2019 and 2026 European Market Share (%) for Sequencing in Molecular Diagnostics by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 127: European Market Analysis (2017-2026) for Hybridization in Molecular Diagnostics by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 128: Glance at 2017, 2019 and 2026 European Market Share (%) for Hybridization in Molecular Diagnostics by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 129: European Market Analysis (2017-2026) for Other Technologies in Molecular Diagnostics by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 130: Glance at 2017, 2019 and 2026 European Market Share (%) for Other Technologies in Molecular Diagnostics by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 131: European Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 132: Glance at 2017, 2019 and 2026 European Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 133: European Molecular Diagnostics Reagents & Consumables Market Analysis (2017-2026) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 134: Glance at 2017, 2019 and 2026 European Molecular Diagnostics Reagents & Consumables Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 135: European Molecular Diagnostics Instruments Market Analysis (2017-2026) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 136: Glance at 2017, 2019 and 2026 European Molecular Diagnostics Instruments Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 137: European Molecular Diagnostics Software & Services Market Analysis (2017-2026) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 138: Glance at 2017, 2019 and 2026 European Molecular Diagnostics Software & Services Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 139: European Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 140: Glance at 2017, 2019 and 2026 European Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 141: European Market Analysis (2017-2026) for Molecular Diagnostics in Infectious Diseases by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 142: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Infectious Diseases by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 143: European Market Analysis (2017-2026) for Molecular Diagnostics in Oncology by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 144: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Oncology by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 145: European Market Analysis (2017-2026) for Molecular Diagnostics in Blood Testing by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 146: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Blood Testing by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 147: European Market Analysis (2017-2026) for Molecular Diagnostics in Genetic Testing by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 148: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Genetic Testing by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 149: European Market Analysis (2017-2026) for Molecular Diagnostics in Prenatal Testing by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 150: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Prenatal Testing by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 151: European Market Analysis (2017-2026) for Molecular Diagnostics in Other Applications by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 152: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Other Applications by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 153: European Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 154: Glance at 2017, 2019 and 2026 European Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other
  • Chart 155: European Market Analysis (2017-2026) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 156: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 157: European Market Analysis (2017-2026) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 158: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 159: European Market Analysis (2017-2026) for Molecular Diagnostics in Other End-Use Sector by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 160: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Other End-Use Sector by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe

Germany

  • Chart 161: German Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 162: German Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 163: Glance at 2017, 2019 and 2026 German Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 164: German Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 165: Glance at 2017, 2019 and 2026 German Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 166: German Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 167: Glance at 2017, 2019 and 2026 German Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 168: German Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 169: Glance at 2017, 2019 and 2026 German Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

France

  • Chart 170: French Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 171: French Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 172: Glance at 2017, 2019 and 2026 French Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 173: French Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 174: Glance at 2017, 2019 and 2026 French Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 175: French Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 176: Glance at 2017, 2019 and 2026 French Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 177: French Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 178: Glance at 2017, 2019 and 2026 French Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

The United Kingdom

  • Chart 179: United Kingdom Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 180: United Kingdom Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 181: Glance at 2017, 2019 and 2026 United Kingdom Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 182: United Kingdom Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 183: Glance at 2017, 2019 and 2026 United Kingdom Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 184: United Kingdom Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 185: Glance at 2017, 2019 and 2026 United Kingdom Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 186: United Kingdom Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 187: Glance at 2017, 2019 and 2026 United Kingdom Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Italy

  • Chart 188: Italian Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 189: Italian Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 190: Glance at 2017, 2019 and 2026 Italian Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 191: Italian Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 192: Glance at 2017, 2019 and 2026 Italian Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 193: Italian Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 194: Glance at 2017, 2019 and 2026 Italian Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 195: Italian Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 196: Glance at 2017, 2019 and 2026 Italian Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Spain

  • Chart 197: Spanish Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 198: Spanish Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 199: Glance at 2017, 2019 and 2026 Spanish Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 200: Spanish Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 201: Glance at 2017, 2019 and 2026 Spanish Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 202: Spanish Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 203: Glance at 2017, 2019 and 2026 Spanish Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 204: Spanish Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 205: Glance at 2017, 2019 and 2026 Spanish Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Rest of Europe

  • Chart 206: Rest of Europe Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 207: Rest of Europe Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 208: Glance at 2017, 2019 and 2026 Rest of Europe Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 209: Rest of Europe Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 210: Glance at 2017, 2019 and 2026 Rest of Europe Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 211: Rest of Europe Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 212: Glance at 2017, 2019 and 2026 Rest of Europe Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 213: Rest of Europe Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 214: Glance at 2017, 2019 and 2026 Rest of Europe Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

ASIA-PACIFIC

  • Chart 215: Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 216: Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 217: Glance at 2017, 2019 and 2026 Asia-Pacific Molecular Diagnostics Market Share (%) by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
  • Chart 218: Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 219: Glance at 2017, 2019 and 2026 Asia-Pacific Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 220: Asia-Pacific Market Analysis (2017-2026) for PCR in Molecular Diagnostics by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 221: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for PCR in Molecular Diagnostics by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
  • Chart 222: Asia-Pacific Market Analysis (2017-2026) for Sequencing in Molecular Diagnostics by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 223: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Sequencing in Molecular Diagnostics by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
  • Chart 224: Asia-Pacific Market Analysis (2017-2026) for Hybridization in Molecular Diagnostics by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 225: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Hybridization in Molecular Diagnostics by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
  • Chart 226: Asia-Pacific Market Analysis (2017-2026) for Other Technologies in Molecular Diagnostics by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 227: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Other Technologies in Molecular Diagnostics by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
  • Chart 228: Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 229: Glance at 2017, 2019 and 2026 Asia-Pacific Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 230: Asia-Pacific Molecular Diagnostics Reagents & Consumables Market Analysis (2017-2026) by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 231: Glance at 2017, 2019 and 2026 Asia-Pacific Molecular Diagnostics Reagents & Consumables Market Share (%) by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
  • Chart 232: Asia-Pacific Molecular Diagnostics Instruments Market Analysis (2017-2026) by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 233: Glance at 2017, 2019 and 2026 Asia-Pacific Molecular Diagnostics Instruments Market Share (%) by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
  • Chart 234: Asia-Pacific Molecular Diagnostics Software & Services Market Analysis (2017-2026) by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 235: Glance at 2017, 2019 and 2026 Asia-Pacific Molecular Diagnostics Software & Services Market Share (%) by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
  • Chart 236: Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 237: Glance at 2017, 2019 and 2026 Asia-Pacific Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 238: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Infectious Diseases by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 239: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Infectious Diseases by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
  • Chart 240: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Oncology by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 241: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Oncology by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
  • Chart 242: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Blood Testing by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 243: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Blood Testing by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
  • Chart 244: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Genetic Testing by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 245: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Genetic Testing by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
  • Chart 246: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Prenatal Testing by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 247: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Prenatal Testing by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
  • Chart 248: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Other Applications by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 249: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Other Applications by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
  • Chart 250: Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 251: Glance at 2017, 2019 and 2026 Asia-Pacific Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other
  • Chart 252: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 253: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
  • Chart 254: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 255: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
  • Chart 256: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Other End-Use Sector by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 257: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Other End-Use Sector by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific

China

  • Chart 258: Chinese Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 259: Chinese Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 260: Glance at 2017, 2019 and 2026 Chinese Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 261: Chinese Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 262: Glance at 2017, 2019 and 2026 Chinese Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 263: Chinese Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 264: Glance at 2017, 2019 and 2026 Chinese Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 265: Chinese Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 266: Glance at 2017, 2019 and 2026 Chinese Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Japan

  • Chart 267: Japanese Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 268: Japanese Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 269: Glance at 2017, 2019 and 2026 Japanese Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 270: Japanese Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 271: Glance at 2017, 2019 and 2026 Japanese Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 272: Japanese Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 273: Glance at 2017, 2019 and 2026 Japanese Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 274: Japanese Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 275: Glance at 2017, 2019 and 2026 Japanese Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

India

  • Chart 276: Indian Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 277: Indian Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 278: Glance at 2017, 2019 and 2026 Indian Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 279: Indian Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 280: Glance at 2017, 2019 and 2026 Indian Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 281: Indian Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 282: Glance at 2017, 2019 and 2026 Indian Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 283: Indian Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 284: Glance at 2017, 2019 and 2026 Indian Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

South Korea

  • Chart 285: South Korean Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 286: South Korean Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 287: Glance at 2017, 2019 and 2026 South Korean Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 288: South Korean Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 289: Glance at 2017, 2019 and 2026 South Korean Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 290: South Korean Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 291: Glance at 2017, 2019 and 2026 South Korean Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 292: South Korean Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 293: Glance at 2017, 2019 and 2026 South Korean Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Rest of Asia-Pacific

  • Chart 294: Rest of Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 295: Rest of Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 296: Glance at 2017, 2019 and 2026 Rest of Asia-Pacific Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 297: Rest of Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 298: Glance at 2017, 2019 and 2026 Rest of Asia-Pacific Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 299: Rest of Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 300: Glance at 2017, 2019 and 2026 Rest of Asia-Pacific Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 301: Rest of Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 302: Glance at 2017, 2019 and 2026 Rest of Asia-Pacific Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

REST OF WORLD

  • Chart 303: Rest of World Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 304: Rest of World Molecular Diagnostics Market Analysis (2017-2026) by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
  • Chart 305: Glance at 2017, 2019 and 2026 Rest of World Molecular Diagnostics Market Share (%) by Geographic Region - Brazil, Argentina, Israel and Other Countries
  • Chart 306: Rest of World Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 307: Glance at 2017, 2019 and 2026 Rest of World Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 308: Rest of World Market Analysis (2017-2026) for PCR in Molecular Diagnostics by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
  • Chart 309: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for PCR in Molecular Diagnostics by Geographic Region - Brazil, Argentina, Israel and Other Countries
  • Chart 310: Rest of World Market Analysis (2017-2026) for Sequencing in Molecular Diagnostics by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
  • Chart 311: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Sequencing in Molecular Diagnostics by Geographic Region - Brazil, Argentina, Israel and Other Countries
  • Chart 312: Rest of World Market Analysis (2017-2026) for Hybridization in Molecular Diagnostics by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
  • Chart 313: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Hybridization in Molecular Diagnostics by Geographic Region - Brazil, Argentina, Israel and Other Countries
  • Chart 314: Rest of World Market Analysis (2017-2026) for Other Technologies in Molecular Diagnostics by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
  • Chart 315: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Other Technologies in Molecular Diagnostics by Geographic Region - Brazil, Argentina, Israel and Other Countries
  • Chart 316: Rest of World Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 317: Glance at 2017, 2019 and 2026 Rest of World Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 318: Rest of World Molecular Diagnostics Reagents & Consumables Market Analysis (2017-2026) by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
  • Chart 319: Glance at 2017, 2019 and 2026 Rest of World Molecular Diagnostics Reagents & Consumables Market Share (%) by Geographic Region - Brazil, Argentina, Israel and Other Countries
  • Chart 320: Rest of World Molecular Diagnostics Instruments Market Analysis (2017-2026) by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
  • Chart 321: Glance at 2017, 2019 and 2026 Rest of World Molecular Diagnostics Instruments Market Share (%) by Geographic Region - Brazil, Argentina, Israel and Other Countries
  • Chart 322: Rest of World Molecular Diagnostics Software & Services Market Analysis (2017-2026) by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
  • Chart 323: Glance at 2017, 2019 and 2026 Rest of World Molecular Diagnostics Software & Services Market Share (%) by Geographic Region - Brazil, Argentina, Israel and Other Countries
  • Chart 324: Rest of World Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 325: Glance at 2017, 2019 and 2026 Rest of World Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 326: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Infectious Diseases by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
  • Chart 327: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Infectious Diseases by Geographic Region - Brazil, Argentina, Israel and Other Countries
  • Chart 328: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Oncology by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
  • Chart 329: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Oncology by Geographic Region - Brazil, Argentina, Israel and Other Countries
  • Chart 330: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Blood Testing by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
  • Chart 331: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Blood Testing by Geographic Region - Brazil, Argentina, Israel and Other Countries
  • Chart 332: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Genetic Testing by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
  • Chart 333: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Genetic Testing by Geographic Region - Brazil, Argentina, Israel and Other Countries
  • Chart 334: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Prenatal Testing by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
  • Chart 335: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Prenatal Testing by Geographic Region - Brazil, Argentina, Israel and Other Countries
  • Chart 336: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Other Applications by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
  • Chart 337: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Other Applications by Geographic Region - Brazil, Argentina, Israel and Other Countries
  • Chart 338: Rest of World Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 339: Glance at 2017, 2019 and 2026 Rest of World Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other
  • Chart 340: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
  • Chart 341: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - Brazil, Argentina, Israel and Other Countries
  • Chart 342: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
  • Chart 343: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - Brazil, Argentina, Israel and Other Countries
  • Chart 344: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Other End-Use Sectors by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
  • Chart 345: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Other End-Use Sectors by Geographic Region - Brazil, Argentina, Israel and Other Countries

Brazil

  • Chart 346: Brazilian Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 347: Brazilian Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 348: Glance at 2017, 2019 and 2026 Brazilian Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 349: Brazilian Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 350: Glance at 2017, 2019 and 2026 Brazilian Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 351: Brazilian Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 352: Glance at 2017, 2019 and 2026 Brazilian Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 353: Brazilian Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 354: Glance at 2017, 2019 and 2026 Brazilian Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Argentina

  • Chart 355: Argentinean Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 356: Argentinean Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 357: Glance at 2017, 2019 and 2026 Argentinean Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 358: Argentinean Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 359: Glance at 2017, 2019 and 2026 Argentinean Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 360: Argentinean Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 361: Glance at 2017, 2019 and 2026 Argentinean Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 362: Argentinean Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 363: Glance at 2017, 2019 and 2026 Argentinean Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Israel

  • Chart 364: Israeli Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 365: Israeli Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 366: Glance at 2017, 2019 and 2026 Israeli Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 367: Israeli Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 368: Glance at 2017, 2019 and 2026 Israeli Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 369: Israeli Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 370: Glance at 2017, 2019 and 2026 Israeli Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 371: Israeli Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 372: Glance at 2017, 2019 and 2026 Israeli Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Other ROW Countries

  • Chart 373: Other Countries Molecular Diagnostics Market Analysis (2017-2026) in USD Million
  • Chart 374: Other ROW Countries Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
  • Chart 375: Glance at 2017, 2019 and 2026 Other ROW Countries Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
  • Chart 376: Other ROW Countries Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
  • Chart 377: Glance at 2017, 2019 and 2026 Other ROW Countries Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
  • Chart 378: Other ROW Countries Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
  • Chart 379: Glance at 2017, 2019 and 2026 Other RoW Countries Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
  • Chart 380: Other ROW Countries Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
  • Chart 381: Glance at 2017, 2019 and 2026 Other ROW Countries Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Tables:

  • Table 1: Nanotechnologies and Its Uses in Molecular Diagnostics
  • Table 2: Most Recent Molecular Diagnostic Product Approvals
  • Table 3: List of some popular Infectious diseases and its Particulars
Back to Top
전화 문의
F A Q